CureVac to Shift Focus of COVID-19 Vaccine Development to Second-Generation mRNA Technology – Webcast & Conference Call

Cookies are blocked. You have to allow cookies to start the session. (More)

10/12/2021 | 09:00 am EDT

CureVac AG

CureVac to Shift Focus of COVID-19 Vaccine Development to Second-Generation mRNA Technology – Webcast & Conference Call

First Name*:

Last Name*:

Company*:

Email*:

I have read the notice on the protection of my personal data and accept it.